Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Joana Liberal

Joana Liberal

University of Coimbra Portugal

 Marija Mazor

Marija Mazor

Orléans University France

Irmak Dik

Irmak Dik

University of Selcuk Turkey

Jitka Rychlíčková

Jitka Rychlíčková

Hospital Na Bulovce Czech Republic

Shirly Kumala

Shirly Kumala

Pancasila University Srengseng Sawah Indonesia

 Joseph Jampilek

Joseph Jampilek

University of veterinary and Pharmaceutical Sciences Brno Czech Republic

Valentina Marinkovic

Valentina Marinkovic

University of Belgrade Serbia

Solomon Habtemariam

Solomon Habtemariam

University of Greenwich Director, Pharmacognosy Research Laboratories UK

Euro industrial pharma 2019

About Conference


We are honored and delighted to welcome you to attend 16th World Congress on Industrial Pharma and Cosmetic Sciences” to be held at Paris, France during March 01-02, 2019. The projected theme of the conference is Transforming technology and its usage in cosmetic and pharmaceutical industry”.

Our ambition is to layout the bridge and enhance  a network where our scientists, industry related researchers and contributors of related field can share their ideas, modern day research, their experience, associated problems, imaginative theories, frameworks, methodologies, tools, applications and questions throughout the scientific community. This conference provides the best opportunities to inspire and influence the largest assemblage of contributors from the field of industrial pharma and cosmetic sciences.

This conference provides a platform that mainly focuses on pharmaceutical and cosmetic formulations, type of material used in pharmaceutical and cosmetic industry, contribution of technology in the field of pharma and cosmetics, novel drug delivery techniques, drug discovery, drug design and drug development, Challenges in pharma and cosmetic research and development. Understanding the customer requirements, need of new strategies in cosmetic and pharmaceutical sector to grow eventually with time.

This conference comprises of various sessions including: special keynote sessions, panel discussions, and poster presentations, young researcher forums, E-posters conducted by the most outstanding and renowned speakers in the field of industrial pharmaceutical.

Sessions

Active Pharmaceutical Ingredients
API is a chemical or basic drug itself with the desired medicinal (pharmaceutical) properties but cannot be used in its raw form. API in crude form may not show proper suitability towards drug metabolism (biotransformation of pharmaceutical substances in the body) pharmacodynamics (effect of drugs and the mechanism of their action in the body) and pharmacokinetics (drug movement within the body) parameters. Therefore in a drug there are mainly two components: API (chief therapeutic entity in a drug product.) and excipient (vehicle or medium for the API delivery). They don't have any pharmaceutical action.
API form that is used in a formulation is often the most thermodynamically stable crystalline form. API is often referred to as “bulk pharmaceuticals,” .Chemical plants in every country make bulk pharmaceuticals
 
Pharmaceutical Formulations & Technology
Pharmaceutical industry discovers, develops, produces, and markets drugs for use of medications. Pharmaceutical formulation is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. Pharmaceutical Pre-formulation development is the first stage during which the physicochemical properties of the drug substance are characterised and established.
Types of pharmaceutical formulations: Parenteral Formulations (are used with intravenous, subcutaneous, intramuscular, and intra-articular administration), Modified drug release formulations, Oncological Formulations, Stomach Floating Formulations (are developed for the drugs that are locally active and have narrow absorption window in stomach, unstable in the intestinal environment and exhibit low solubility at high pH values. Hence they are made float in gastric environment by using suitable polymers), Microcapsulated drug formulations, Manufacture and formulation of fixed-dose combination.
Technology include computer modelling for research, bioengineering for research instrumentation, chemical engineering, genetic engineering, phyto-chemistry, combinatorial and polymer chemistry (for synthesis of new polymers like PGA), computing technology and biosystematics for the management and analysis of data(such as in vitro drug release, calculation of elimination rate constant, controlled drug delivery, use of nanotechnology in pharmaceuticals and much more.
 
Pharmaceutical Manufacturing Operations
Production of bulk drug substances depends upon processes like fermentation (for production of antibiotics, steroids and vitamins), organic chemical synthesis (to produce drug substances with unique properties) and natural/biological extraction (metabolites isolation). Before administration in living organisms drug substances are converted to dosage form (solubilized dosage forms, supersaturated drug concentration to enhance oral absorption) like tablets, capsules and sterile liquids for injection are common dosage forms.
The process of drug manufacturing can be broken down into a series of unit operations, such as weighing and dispensing, milling, granulation, coating, tablet pressing, compression, blending and others. Pharmaceutical necessities (like binders, fillers, flavouring agents, bulking agents, antioxidants, emulsifiers and pharmaceutical solvents etc.) having no or limited therapeutic value but used in pharmaceutical preparations.
 
Drug Discovery, Design and Drug Development
Drug discovery involves the identification of screening hits, medicinal chemistry and optimisation of those hits to increase the affinity, selectivity (to reduce the potential of side effects), efficacy/potency and metabolic stability (to increase the half-life), oral bioavailability. Hot trends in pharmaceutical industry for drug discovery include Mass spectrometry drug discovery, Adoption of artificial intelligence, Targeting RNA with small molecules, Phenotypic screening Organ-on-chips etc. Once a compound that fulfils all of these requirements has been identified, it will begin the process of drug development.  Use of Enzymes and proteins are the current trend in pharmaceutical synthesis. Pharmaceutical chemist, toxicologist and medicinal chemist play important role in development of drugs.
Drug design is the inventive process of finding new medications based on the knowledge of a biological target. It involves the design of molecules that are complementary in shape and charge to the bimolecular target with which they interact and therefore will bind to it. Computer-Aided Drug Design (CADD) is a specialized discipline that uses computational methods to simulate drug-receptor interactions. CADD methods are heavily dependent on bioinformatics tools, information technology, information management, software applications, databases and computational resources all provide the infrastructure for bioinformatics.
Computer-assisted drug design supports drug discovery by suggesting novel chemotypes and compound modifications for lead structure optimization and software’s for de novo drug design with a special emphasis on fragment-based techniques helps to generate drug like, synthetically accessible compounds. Drug design that relies on the knowledge of the three-dimensional structure of the bimolecular target is known as structure-based drug design. Before drug launch in market it is important to know what will be the effect of the drug on the body, effectiveness on the disease being targeted, Undesirable side effects of the drug.
 
Novel Drug Delivery Techniques
The Novel Drug Delivery Systems are the method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentration above or below this range can be toxic or produce no local drug delivery system benefits at all. To overcome the limitations of conventional drug delivery systems advanced controlled drug delivery systems or smart drug delivery(molecular and Nano) systems with stimuli-responsive characteristics have been developed to achieve the release of payloads at the target sites in a spatial controlled manner.
 There are different types of drug delivery vehicles, such as polymeric micelles, liposomes lipoprotein-based drug carriers, Nano-particle drug carriers, dendrimers, etc. An ideal drug delivery vehicle must be non-toxic, biocompatible, and non-immunogenic. The most reported use of nanotechnology in drug delivery under development is the use of nanoparticles to deliver and transport drugs to diseased and damaged cells and is called Nano drug delivery. Ophthalmic Drug Delivery is the administration of drug through the eyes, mostly as an eye drop formulation. Ophthalmic drug delivery systems have developed a major impact for the treatment of retinal diseases. Pulmonary drug delivery for the treatment of several chronic diseases has led to the development of targeted drug delivery systems.
Biodegradable nanoparticles formulated from poly (D,L-lactide-co-glycolide) (PLGA) have been extensively investigated for sustained and targeted/localized delivery of different agents including plasmid DNA, proteins and peptides and low molecular weight compounds. Liposomes are lipid based nanostructures. Liposomes have been the most investigated Nano drug delivery in veterinary medicine. Liposomes and nanoparticles have been extensively investigated as drug delivery systems for anticancer agents due to their ability to target cancerous cells and reduce the negative side effects of free cytostatic drugs. Hydrogels have been used to deliver hydrophilic, small-molecule drugs which have high solubility. Other method includes Antibody targeted-drug conjugates, gene delivery, self-emulsifying drug delivery systems. Transdermal drug delivery is the administration of drug through the skin. Devices and formulations for transdermal administered substances include: Transdermal patch, specially formulated sprays and transdermal gel.
 
Pharma Digitalisation and trends reshaping healthcare
Technology has become a key differentiator and digitalisation stands tall as the major differentiator. Digitalisation provides a platform for the organizations, especially the ones actively involved in the manufacturing, research and development. We can see visible benefits in the areas of se­cured collaborative research, Quality by Design (QBD), Modelling and simulation in process development besides analytics and visualizations. . Digitalization has already made inroads into sales and mar­keting and has made significant positive impact on business.
Digitalisation helps in improving collaboration between various elements. The combined framework of integrated instruments, specific software and standardized hardware, information technology and the internet brings greater visibility to R&D processes. Digitalisation also reshaping healthcare system by providing:Personalized care( Sensors and digital services for smart 24/7 treatment), Omnichannel conversations with physicians and patients, Efficient clinical trial data management etc.
 
Biopharmaceuticals and Nano biopharmaceuticals
A biopharmaceutical is any pharmaceutical drug product that has been manufactured, extracted from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, and blood components, allergenic, somatic cells and therapeutic protein. They are isolated from living sources—human, animal, plant, fungal, or microbial.
Biosimilars refers to similar biological medicinal products that can contribute to the reduction of costs to the patients and healthcare systems.Another method of producing biopharmaceuticals involves use of genetically modified microorganisms, animals and plants. Nano biopharmaceuticals   are useful in the targeted drug delivery process because they can deliver drugs to site-specific targets, allowing drugs to be delivered in certain specific organs or cells.
Commercialization and large scale production of Nano biopharmaceuticals biopharmaceutical companies can typically apply for patents that can grant exclusive manufacturing rights. This is the primary means by which the developer of the drug can recover the investment cost for development of the biopharmaceutical.
 
Biotechnology and Microbiology applications in Pharmaceutical Industry
Modern pharmaceutical manufacturing techniques frequently rely upon biotechnology particularly for hormone production, manufacturing and genetic testing etc. Recombinant DNA technology is used to modify Escherichia coli bacteria to produce human insulin. Other examples include use of transgenic yeast to produce artemisinin, production of Human growth hormone, blood clotting factors. Biotech makes use of molecule products and concepts which is also the prerequisite of pharmaceutical companies. The production costs of biotech based products are cheaper and this is a major reason why the pharma industry embraced this technology.
Radiopharmaceuticals are a group of pharmaceutical drugs that can be used either for diagnostic or therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The radioisotope is selected for its properties.Pharmacists and microbiologists work synergistically to ensure that drug therapies target the opportunistic microbes without harming its human host. Understanding the principles of microbiology and human cell mechanisms allows pharmacists to discover antimicrobial drugs. The roles of microbiology on the advances pharmaceutical and medical industry have led to great discoveries, from vaccines to devices.
 
Advanced Pharmaceutical Analysis Techniques
Pharmaceutical analytical techniques deal with different processes to identify or quantify a substance, the components of a pharmaceutical solution or the determination of the structures of chemical compounds used in the formulation of pharmaceutical product.
Instrumental methods are generally preferred due to their high speed, selectivity, specificity, accuracy and simplicity of analysis. Any change in the properties of the system are detected by measurement of absorbance, specific rotation, refractive index, migration difference, charge to mass ratio etc. Methods includes are:Spectral Methods: To measure electromagnetic radiation. For example UV spectroscopy, NMR, flourimetry etc. Chromatographic Methods: HPLC, GLC, TLC etc. Electro analytical methods:  To measure current, voltage, resistance. For example Potentiometer, conductometry etc.
 
Quality control and Quality assurance
QC department play key role in any pharma company. QC scientists (chemist or microbiologist) test samples from all phases of a manufacturing or other handling process, with the goal of determining if the substance meets the requirements or standards. Quality will be checked in different stages: raw material analysis, in process sample analysis and finished product analysis, sterility testing (membrane filtration sterility testing, fluid path sterility testing, rapid sterility testing etc.). The QC had two different divisions: wet analysis and instrumental analysis.
QA refers to the step-by-step process of examining whether goods and services meet specific quality, efficacy and safety requirements, as per their intended use. Pharmaceutical companies follow SOPs to achieve efficiency, quality output and uniformity of performance, while reducing miscommunication and failure to comply with industry regulations.
GMP (Good Manufacturing Practice) is the part of quality management, which ensures that products are consistently produced and controlled according to the quality standards. GMP aimed primarily at managing and minimizing the raw material adulteration risks, to minimize the adulterations during production phase and to ensure the quality, safety and efficacy of products.
 
 
Packaging, labelling and delivery system
Packaging and labelling are two vital requisite of the pharmaceutical and cosmetic industry. All above that quality of packaging and labelling is also important for maintaining the product quality.Labels should be designed as such that they remain in place invariant during distribution, supply and storage. The label should tell about the official product name, active and inactive ingredients, drug facts table, use, warnings and allergic reactions. Categories of Pharmaceutical packaging material are:
Primary Packaging material: The material that first envelops the product and holds it e.g. prefilled syringes, ampoules and vials, glass container etc. Secondary packaging system is outside the primary packaging and used to group primary packages together e.g., cartons, boxes, shipping containers, injection trays, etc. Tertiary packaging system is used for bulk handling and shipping e.g., barrel, container, edge protectors, etc. Packing technologies include Blow-fill-seal technology, Anti-Counterfeiting packaging technology etc. Other important aspects of delivery systems includes packaging design, type of material used, sealing system, security labels, Holographic labels, sequential product number, embedded image, Hidden marks and printing, mass encoding(trace and track technology),Barcodes etc.
 
Challenges for cosmetic and pharmaceutical industry
Policy reform any changes to healthcare with a new presidential administration will undoubtedly have an impact on the pharmaceutical industry. The challenge to the pharmaceutical industry will be to enforce change while maintaining steady market growth. Slowed market growth is one of the most worrying aspects of the pharmaceutical industry. Regulations and approval by government agencies are difficult for all industries, but there is a lot of pressure on governments to have stricter controls on cosmetic and pharmaceutical industry. Key areas of concern for companies are annual fees, drug approvals, advertising and marketing. Other challenges include Sustainability challenges, impact of pharmaceutical and personal care products in environment, more options for customer, sustainability packaging, green formulations and social impacts.
Pharmaceutical waste management/treatment has        great importance because of Healthy related issues (Irritant, toxic, radioactive) and Safety related issues (flammable, reactive etc.).Treatment of industrial waste is very important because improper disposal may have an adverse effect on land and aquatic system. The failure or proper waste management and inability to reuse such materials result in depletion of natural resources.
 
Impact of pharmaceuticals on environment
Pharmaceuticals, over-the – counter medications and personal care products are the common environmental pollutants. These products typically enter the environment when passed through or washed off the body and into the ground or sewer lines, or when disposed of in the trash, septic tank, or sewage system. Major route for pharmaceutical residues to reach the aquatic environment, soil and in atmosphere is most probably by excretion from patients undergoing pharma treatment. Since many pharmaceutical substances are not metabolized in the body they may be excreted in biologically active form, usually via the urine. Adverse health outcomes are displayed in aquatic organisms.
In addition to the growing concerns about human health risks from pharmaceutical drugs via environmental exposures, the main threats is that discharging antibiotics into the environment can promote the natural development of antibiotic-resistant pathogens that are harder to treat.The increased presence of estrogen and other synthetic hormones in waste water due to birth control and hormonal therapies has been linked to increased feminization of exposed fish and other aquatic organisms. The chemicals within these PPCP products could either affect the feminization or masculinization of different fishes, therefore affecting their reproductive rates.
 
Cosmetics and Toiletries
Nutricosmetics refers to products and ingredients that act as nutritional supplements but carry the purpose of treating the skin. These are a leading trend in the industries and are more commonly referred to as Beauty Supplements. . Organic cosmetics are products that are made with organic ingredients. Cosmetic pigments are used in the production of cosmetic colorants, to create the wide colourful range of lipsticks, eye colours, nail enamels etc. Inorganic Colour Pigments consisting of Inorganic Colorants, Blended Inorganic and Lo Micron colours like Iron Blue or Ferric Ferrocyanide used to add dark blue colouring to cosmetics. Iron oxide is added to achieve red, yellow and black colours for cosmetics. Manganese Violet is utilised in cosmetics such as nail paints, lip sticks, hair colours and in personal care products such as skin creams, shower gels, shampoo, toothpaste, deodorant etc. Cosmetic Dyes are available in oil soluble colours and water soluble colours for cosmetics and personal care. These applications depend on the formulation of the product. Water soluble cosmetic colours are used for opaque cosmetic products to give them a light tint. These are perfect for lotion, soaps, powders etc. Oxides and ultramarines are some of the oil soluble cosmetic colours. Other pigments are pearlescent pigments, bismuth oxychloride-based pigments, calcium sodium borosilicate-based pigments, mica-based pigments             , themochromic materials, photochromic materials etc. OTC (over –the-counter) drugs or non-prescription medicine can be purchased without prescription.
 
Cosmetic Technology
Cosmetic science is the study of the effects that raw materials and mixtures can have on parts of the human body like hair, skin, lips and nails. Main research area for cosmetic scientists are polymer chemistry, dermal pharmacology, microtoxicity, quality assurance, formulations, cosmetic chemistry, pharmaceutical and cosmetic science etc. Cosmetic formulation design is a multidisciplinary and challenging area of focus for the cosmetic industry. It involves the incorporation of scientific understanding from colloidal science and complex fluids to generate products with good stability profiles such as use of biopolymers, smart complex fluids and gels, microparticles, and nanoparticles, green and novel bio-surfactants in cosmetics. Preservatives are required to stop microbes from spoiling product and to increase the product life. Common cosmetic preservatives used in cosmetic and personal care products are parebens, formaldehyde donors, phenol derivatives, quats, isothiazolones and organic acids.
Digitalisation trending in cosmetic industry example: Smart cosmetics, Neutrogena 360 is a 3D scanning technology powered device for  skincare that analyses skin over time and offers product recommendations. ‘‘Makeup genius” first virtual makeup application that instantly applies makeup to the consumers face. ModiFace Skin AI (artificial intelligence) this tool was developed by dermatologist to measure the precise state of skin.
 
Cosmetic Dermatology, Trichology and Gynaecology
Cosmetic Dermatology focuses on the improvement, enhancement and appearance of skin, hair and nails aesthetically, artistically and cosmetically. Treatments at Advanced Dermatology (ADCS) range from deep cleansing, refreshing, rejuvenating, and restoring skin texture and tone, to reducing skin imperfections. Dermatological diseases or abnormalities such as eczema, contact with allergens, irritants, and bacteria trapped in pore and hair follicles. These incorporate textural irregularities, acne, scars, stretch marks, skin discolouration and dermatitis, wrinkles, skin inflammation scars, pigmentation changes. Immune-dermatology (immune system problems can cause dermatitis, hives and may develop several kinds of cancers). Dermal filers and injectable   (Botox cosmetic, collagen treatment, microlipoinjection etc.) reduce the appearance of skin wrinkling.
Dry scalp can cause dandruff .Treatment for hair conditioning includes use of medicated and mild shampoo, scalp massage, vitamin B6 and B12 supplements use. Hair restoration means some form of reversal of hair-loss either by regrowing the hair, replacing the hair surgically, or replacing the hair cosmetically. Surgical hair restoration procedures include Follicular unit transplant (FTU), follicular unit extraction (FEU).Non-surgical hair restoration procedure include scalp micropigmentation. Several factors associated with Hair loss or alopecia these may be improper diet, microbial infection etc. Hair miniaturization is the hormone-driven biological process in which hair shrink in size over time, eventually leaving a bald scalp. To strengthen hair and to improve the hair texture keratin treatment is general recommended.
The aim of cosmetic gynaecology is to improve the physical appearance or functionality of the labia and vagina. It covers a variety of surgical procedures including labia reduction or labiaplasty, vaginal tuck, vaginoplasty or vaginal rejuvenation and hymenoplasty whereas in non-surgical procedure such as thermiva instead of using surgical instruments a cosmetic gynaecologist will use radio frequency to treat the intimate tissues, including the labia and vagina.
 
Advances in Cosmetic surgery
Cosmetic surgery entirely focused on enhancing a patient’s appearance. Improving aesthetic appeal, symmetry, and proportion are the key goals. Varieties of procedures are available for different parts of body.To improve body shape Mammoplasty procedures are there such as Breast augmentation, breast reduction, Mastopexy (breast lift), male breast reduction. Facial cosmetic surgery includes: Blepharoplasty, or eyelid surgery, rhinoplasty, otoplasty, and rhytidectomy, chin augmentation, Malar or cheek augmentation.
Tissue engineering makes procedure more realistic and effective. Computer-Assisted Imaging often used in craniofacial surgery, which is performed to correct skeletal deformities in cranium and facial bones. In both cosmetic and reconstructive plastic procedures, the use of imaging gives surgeons exact specificationsChemical peel is used to treat acne, pock marks, scars, or wrinkles. Liposuction: Type of cosmetic surgery that breaks up and "sucks" fat from the body. Weight loss surgery: surgeon usually does the procedure on hips, belly, thigh, buttocks, back, arms or face to improve their shape.Other procedures like soft tissue fillers, laser and light based facial treatment, hair transplantation, buttock augmentation, buttock or lower body lift, abdominoplasty, vulvovaginal surgery.
Cosmetic dentistry mainly focuses on improving the appearance of teeth, gums, position, shape, size, and colour.
 
Complications of Cosmetic Surgery, Risk from Cosmetic and Personal care products
Surgery cannot only improve physical appearance but it can also have emotional and psychological effects. Procedures such as breast enlargement or a facelift could have a great influence on an individual’s self-esteem and confidence levels. Hematoma, Nerve damage, infection, pulmonary embolism, deep vein thrombosis, organ damage, anaesthesia complications, seroma, necrosis, paralysis, psychological and social risk etc. are examples of common complications.
 Chemicals of concern found in products are:Diethanolamine (DEA) used in variety of face makeup and hair products that may cause skin irritation or organ system toxicity. Formaldehyde found in baby shampoo, hair smoothing products, colour cosmetics, eyelash glue and in nail products that may cause high rates of skin allergy reactions or may show carcinogenic effect. Parabens act as preservative agents and commonly used in moisturizers, conditioners, lotions, facial and shower cleansers, shaving products and in scrubs that may act as hormone-disrupters. Triclosan is antimicrobial and preservative agent found in personal care products such as antiperspirant, hand wash and toothpaste the regular use of this may lead to bacterial resistance development, disrupts thyroid and reproductive hormones. Phthalates are used as solvents and can be found in hair products, lotions and nail polish and hardeners. They have been found to have endocrine disruption effects and have been linked with endometriosis and early puberty in girls, reproductive organ abnormalities and reduced fertility in males.
 
 

Market Analysis

Global cosmetic market
Skin care, hair care, makeup, perfumes, toiletries and deodorants, and oral cosmetics are the main product categories of the cosmetic market.In terms of value, USA sales account for 13%-14% of total market share, EU growing at a good pace owing to large population and high economic growth rate occupies the 20% market share of the global consumption value. The increasing demand for skin care drives Cosmetics industry developing fast. The global cosmetic products market was valued at USD 532.43 billion in 2017, and is expected to reach a market value of USD 805.61 billion by 2023, registering a CAGR of 7.14% during 2018-2023.
The leading players in cosmetic product market include L’Oreal Group, Procter & Gamble, Avon Products, Inc. (US), Unilever, Beiersdorf AG etc. These key players continuously invest in R&D to introduce new products as per the market demand. Considering the demand in the market, these companies are also expanding their facilities to increase their production capacity and strengthen their global network.
According to MarketsandMarkets which is a global market research and consulting company based in the U.S. The cosmetic products market is projected to grow at a CAGR of 6.3% with its increasing demand from emerging markets such as Brazil, India, etc. The increasing disposable income, changing fashion trends, and improvement in the living standards of the consumers drive the cosmetic products market.
Global pharmaceutical market
The global pharmaceutical industry is an important aspect of the world economy today, providing about one trillion US dollars in revenues annually. The American pharmaceutical industry accounts for about 40% of these revenues. China is fast catching up as having the fastest growth in the industry. European pharmaceuticals have also shown high revenues in prescription sales.
Reports suggested that pharmaceutical companies show their R&D majorly in following areas:
Advanced drug delivery systems
 Antibiotics, Excipients in pharmaceuticals
 Ophthalmic therapeutics drugs
Skin disease treatment
Vaccine technologies
 Cancer drug development
The vaccine market is expected to reach USD 50.42 billion by 2023 from USD 36.45 billion in 2018, at a CAGR of 6.7%. The nuclear/radiopharmaceuticals medicine market is projected to reach USD 5.26 billion by 2023 from an estimated USD 3.95 billion in 2018 at a CAGR of 5.9%.The global oncology nutrition market is expected to reach USD 2.21 Billion by 2023 from USD 1.46 Billion in 2018, at a CAGR of 8.7%. The drug discovery services market is expected to reach USD 14.40 Billion by 2022 from USD 8.32 Billion in 2017, at a CAGR of 11.6%. The major factors driving the growth of this market are increasing research and development expenditure, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles, and increasing demand for outsourcing of analytical testing and clinical trial services. The global pharmaceutical packaging equipment market is estimated to grow at a CAGR of 6.8% from 2017 to 2022 to reach USD 8.24 Billion approximately by 2022. The growth of the market can be attributed to factors such as cost containment in pharma R&D, growth in funding for generics and biopharmaceutical research, and technological advancements in labelling and serializations solutions.
The US has the largest pharmaceutical market in the world with a value of $339,694 million USD followed by Japan ($94,025 million USD) and China ($86,774 million USD). In Germany, the value of its pharmaceutical market is about $45,828 million USD and in France; it is about $37,156 million USD. In Brazil, the value of its pharmaceutical market is about $30,670 million USD. In Italy, the value is about $27,930 million USD. In the UK, it is about $24,513 million USD while in Canada it is about $21,353 million USD. In Spain, it is about $20,741 million USD.

Past Conference Report

 
Pharma Europe 2018 Report

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners for making Pharma Europe 2018 Conference the best ever!

The 15th Annual European Pharma Congress, hosted by the Conferenceseries LLC LTD  was held during May 07-09, 2018, Frankfurt, Germany based on the theme “Discover and Explore the Future of Pharma". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Pharmacy, who made this event a grand success.

Conferenceseries LLC LTD  expresses its gratitude to the conference Moderators, namely Dr. Eriona Petro  for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

Similarly we also extend our appreciation towards our Poster judges namely, Dr. Solomon Habtamariam. We hope you continue your support in our future endeavours.  

The conference was initiated with the Honourable presence of the Keynote forum. This list includes:
  •  Bimal Roy Krishna, Touro University, USA
 
  •  Solomon Habtemariam, University of Greenwich, UK

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

    Pharmacognosy and Phytochemistry
    Pharmacological Sciences
    Drugs and Regulations
    Pharmaceutical Chemistry
    Types Of Pharmaceutical Formulations
    Nanotechnology
    Novel Drug Delivery Systems
    Bio-Pharmaceutics
    Bioinformatics
    Genetics & Genetic Engineering
    Pharmaceutical Packaging
     Radiopharmaceuticals
    Hospital Pharmacy
    Industrial Pharmacy
    Ethics in Pharmacy
    Pharma Consulting & Services
    Entrepreneurs Investment Meet

Conferenceseries LLC LTD  offers its heartfelt appreciation to organizations such as Crowd Reviews, Atlas of Science and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. Conferenceseries LLC LTD also took privilege to felicitate the Keynote Speakers, Organizing Committee Members and Chairs who supported this event.

With the grand success of Pharma Europe 2018, Conferenceseries LLC LTD is proud to announce the "16th World Congress on Industrial Pharma and Cosmetic Sciences" to be held during March 01-02, 2019 at Paris, France.
For More details visit:https://industrial.pharmaceuticalconferences.com/

To Collaborate Scientific Professionals around the World

Conference Date March 01-02, 2019 |

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Pharmaceutical Regulatory Affairs: Open Access ISSN: 2167-7689 Pharmaceutical Regulatory Affairs: O Pharmaceutica Analytica Acta Drug Designing Journal

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos